Comparability for Biologics December 2, 2008

Process changes made during the manufacture of recombinant proteins can have profound implications on the quality, safety, efficacy and regulatory approval of your product

Official Website: http://www.iir-events.com/IIR-conf/PTI/EventView.aspx?EventID=1316